In the quarter ended March 27, 2026, Dolby Laboratories maintained steady license revenue performance with nuanced accounting treatment of variable consideration factors, emphasizing conservative revenue recognition. The company’s core business revolves around leveraging an extensive portfolio of over 28,000 patents to generate recurring royalty streams from OEMs and semiconductor manufacturers worldwide. Sustained heavy investment in R&D fuels innovation in premium audio/visual solutions such as Dolby Atmos and Vision, securing Dolby’s competitive moat amid evolving entertainment industry dynamics. Key risks include dependence on licensees’ market health and patent expiration, while growth is tied to expanding international cinema penetration and adoption of immersive formats. Financially, Dolby stands on a robust liquidity base evidenced by nearly $600 million in cash and a healthy current ratio of 2.98.